PharmEng International Inc. (PharmEng) is a Canada-based company engaged in the business of pharmaceutical and consulting. The wholly owned subsidiaries of the Company are PharmEng USA, Inc. (PUSA), PharmEng China Inc., PharmEng Taiwan Inc., and PharmEng Technology Inc. (PTI). PTI serves the pharmaceutical, biotechnology and medical device industries in North America and internationally, and a contract pharmaceutical manufacturing business, Keata Pharma Inc. (Keata), serving North American pharmaceutical customers. PTI is also engaged in delivering certification training programs through educational institutions by providing the necessary courseware and instructors for those programs. In May 2007, the Company established a joint venture company in partnership with Beijing BRD Lixin PharmaTech Co. Ltd. of China, known as Beijing PharmEng BRD Lixin PharmaTech Consultation Co. Ltd., in which the Company would own a 51% interest.
(Source: ARS) – less – More from ZoomInfo »